c Recently, the need to distinguish between members of the Mycobacterium abscessus group has gained increasing attention. Here, we introduced a novel peptide nucleic acid (PNA) real-time PCR method targeting the hsp65 gene in order to distinguish between four subspecies within the M. abscessus group (M. abscessus and 3 types of M. massiliense).
T
he taxonomic status of the Mycobacterium abscessus group remains undetermined. The recent development of genetic investigation tools has revealed that the M. abscessus group can be further divided into three closely related taxa, i.e., M. abscessus, M. massiliense and M. bolletii (1) (2) (3) . Recently, it was reported that M. massiliense can be further subdivided into three genotypes (here referred to as types I, II-1, and II-2) based on analyses of the hsp65 sequence (4, 5) . Because M. massiliense differs from M. abscessus in its susceptibility to clarithromycin, distinguishing between the two organisms has clinical importance (6, 7) . Furthermore, phylogenetic separation between three types of M. massiliense has also been reported (4, 8) , highlighting the epidemiological importance of their separation (7, 9, 10) .
Peptide nucleic acids (PNAs) are artificially synthesized DNA analogues with an uncharged peptide backbone (11, 12) . A PNA probe-based real-time PCR assay has been developed for the diagnosis of mycobacterial infections, particularly for distinguishing between Mycobacterium tuberculosis and nontuberculous mycobacteria (NTM) in clinical specimens (13, 14 T , and M. xenopi ATCC 19250 T ), were used in this study. All clinical isolates were collected from the Asan Medical Center (Seoul, Republic of Korea) during the period from January 2004 to June 2011. This work was approved by the institutional review board of Seoul National University Hospital (C-1202-057-398) and the Asan Medical Center (2012-0170). The mycobacteria were maintained as a subculture of a frozen stock before use in molecular assays. Bacterial chromosomal DNA was extracted from the clinical isolates by the bead-beater-phenol extraction method, as described previously (15) .
The primers were designed using the Oligo software (version 6.5; Molecular Biology Insights). These primers produced 377-bp hsp65 amplicons (from nucleotides 380 to 756 in the M. abscessus hsp65 gene). We designed a set of three PNA probes for specific simultaneous detection in a single reaction of the four subspecies of the M. abscessus group (M. abscessus and specific types I, II-1, and II-2) using the LC-PDS (version 2.0) software. The probes were further developed according to the design guidelines of the PNA manufacturer, using three different single nucleotide polymorphisms (SNPs) within 604-bp hsp65 sequences (see Fig. S1 in the supplemental material). We used these reporter dyes to detect different sequences: 6-carboxyfluorescein (FAM) for the detection of M. abscessus and M. massiliense at the subspecies level, Hex for discriminating M. massiliense type I and type II, and Texas Red for discriminating M. massiliense types II-1 and II-2 (see Table S1 in the supplemental material). A LightCycler (version 96) system was used for real-time PCR. To evaluate the results obtained by hsp65 PNA real-time PCR for the identification of 228 clinical isolates, PCR direct sequencing was performed as previously described (15 were clearly separated from all other mycobacterial species using the FAM channel, showing the specific melting temperatures of the respective strains (data not shown).
To evaluate the usefulness of the method developed for the identification of M. abscessus members, we tested a total of 228 clinical isolates that included 99 M. abscessus and 129 M. massiliense strains in a blinded fashion. In comparison with the results obtained by the hsp65 direct sequencing protocol, the PNA-based method enabled the identification of 227 of 228 isolates (99.6%) as 99 M. abscessus and 128 M. massiliense strains. Further, this approach also differentiated all 128 M. massiliense isolates into three genotypes, I-1 (71 isolates), II-1 (49 isolates), and II-2 (8 isolates) (data not shown).
Although our hsp65 PNA real-time PCR differentiated four members of the M. abscessus group in one reaction via a combination of three different probes, this protocol can be modified according to the user's needs. For example, in areas where the presence of the M. massiliense type II genotype has not been reported, a protocol equipped with only one probe, the Mas/Abs probe that differentiates between the M. abscessus and M. massiliense strains, could be applied. In South Korea, using a combination of all three probes is important.
In conclusion, our data suggest that a novel hsp65 PNA-based real-time PCR method might be a promising approach for identifying the subspecies or genotypes of clinical isolates of the M. abscessus group. 
